Drawing for WE LOVE YOUR FAT

USPTO serial 97458501

WE LOVE YOUR FAT

Reviewed by CopyMark Law Group

Reg. 7257671Status 700Registered
Filing date
Status date
Registration date
Jan 2, 2024
Examiner
MOSCATI, JUSTIN RONALD
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WE LOVE YOUR FAT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven Ivy

Steven Ivy STEVEN IVY P.C.2600 OAK STREET#1541SAINT CHARLES, IL 60175

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the field of stem cells.; Business consulting services in the field of specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; International business consulting services relating to specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; International business consulting services relating to stem cells.; Operating on-line marketplaces featuring medical products used for the extraction from blood and processing of regenerative stem cells.; Promoting public awareness of specialized medical services and products, used for extraction and processing of regenerative human cells.; Promoting public awareness of medical services relating to the removal, processing of human blood.; Promoting public awareness of specialized medical services and products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; Promoting public awareness of medical services relating to the removal, processing of stem cells and treatment of medical conditions with the processed stem cells.; Providing purchase advisory and consulting services to consumers for the purchase of medical devices used for removal, treatment and processing of stem cells.; Providing purchase advisory and consulting services to consumers for the purchase of medical products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of wounds.; Wholesale distributorships featuring medical products, namely, microfat processing system used for extracting cells from patient's own blood and converting it into medication for treatment of musculoskeletal disorders, degenerative and inflammatory conditions, dermatological conditions, reduction of pain, rejuvenation of skin, treatment of sexual dysfunctions, restoration of hair, and accelerating healing of woundsACTIVEJun 22, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 12, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 21, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 27, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2023DOCKASSIGNED TO EXAMINER—
Jun 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance